Piper Sandler Maintains Abbvie (ABBV) Overweight Recommendation
29/7 13:42
Fintel reports that on July 28, 2023, Piper Sandler maintained coverage of Abbvie (NYSE:ABBV) with a Overweight recommendation....
|
|
|
29/7 13:42
Fintel reports that on July 28, 2023, Piper Sandler maintained coverage of Abbvie (NYSE:ABBV) with a Overweight recommendation....